rs1064794328
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015450.3(POT1):βc.147delβ(p.Ile49MetfsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000311 in 1,607,744 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. I49I) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015450.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POT1 | NM_015450.3 | c.147del | p.Ile49MetfsTer7 | frameshift_variant | 7/19 | ENST00000357628.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POT1 | ENST00000357628.8 | c.147del | p.Ile49MetfsTer7 | frameshift_variant | 7/19 | 2 | NM_015450.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152076Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1455668Hom.: 0 Cov.: 29 AF XY: 0.00000276 AC XY: 2AN XY: 724208
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152076Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74268
ClinVar
Submissions by phenotype
Long telomere syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | The Telomere Center at Johns Hopkins, Johns Hopkins University School of Medicine | Aug 01, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 10, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); Observed in an individual with glioma and in another individual with multiple cancers including lymphoma, melanoma, and papillary thyroid cancer (Jones et al., 2015; Jajosky et al., 2022); This variant is associated with the following publications: (PMID: 35456397, 25877891) - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2023 | The c.147delT pathogenic mutation, located in coding exon 3 of the POT1 gene, results from a deletion of one nucleotide at nucleotide position 147, causing a translational frameshift with a predicted alternate stop codon (p.I49Mfs*7). This alteration has been reported in an individual diagnosed with glioma (Jones S et al. Sci Transl Med, 2015 Apr;7:283ra53). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Tumor predisposition syndrome 3 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | This sequence change creates a premature translational stop signal (p.Ile49Metfs*7) in the POT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POT1 are known to be pathogenic (PMID: 32155570). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with glioma (PMID: 25877891). ClinVar contains an entry for this variant (Variation ID: 420174). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at